Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation

International Journal of Hematology

Volumn 98, Issue 2, 2013, Pages 258-260

  Motohashi, Kenji ^a   Suzuki, Taisei ^a   Kishimoto, Kumiko ^a   Numata, Ayumi ^a   Nakajima, Yuki ^a   Tachibana, Takayoshi ^a   Ohshima, Rika ^a   Kuwabara, Hideyuki ^a   Tanaka, Masatsugu ^a   Tomita, Naoto ^b   Ishigatsubo, Yoshiaki ^b   Fujisawa, Shin ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti CCR4 antibody; ATLL; Mogamulizumab

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; CARBOPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOSCARNET; GANCICLOVIR; ITRACONAZOLE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MOGAMULIZUMAB; PREDNISOLONE; RANIMUSTINE; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CASE REPORT; DRUG DOSE REDUCTION; DRUG ERUPTION; ENGRAFTMENT SYNDROME; FEMALE; HUMAN; INFUSION RELATED REACTION; LEUKEMIA REMISSION; MAST CELL LEUKEMIA; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; SKIN BIOPSY; T CELL LEUKEMIA; T CELL LYMPHOMA; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

ALLOGRAFTS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MIDDLE AGED; RECEPTORS, CCR4; REMISSION INDUCTION;

EID: 84882244555     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1387-8     Document Type: Article

References (12)

1. Tsukasaki K, Tobinai K, Shimoyama M, et al. Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). Int J Hematol. 2003;77:164-70.
2. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001;113:375-82.
3. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458-64.
4. Itoh K, Ohtsu T, Fukuda H, et al. Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Ann Oncol. 2002;13:1347-55.
5. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116:1369-76.
6. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30:837-42.
7. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79:428-37.
8. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
9. Yabe T, Matsuo K, Hirayasu K, et al. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant. 2008;14:75-87.
10. Tanosaki R, Uike N, Utsunomiya A, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant. 2008;14:702-8.
11. Ito Y, Miyamoto T, Chong Y, et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant. 2013. doi: 10.1038/bmt.2012.268.
12. Ishida T, Ueda R. Antibody therapy for Adult T-cell leukemia-lymphoma. Int J Hematol. 2011;94:443-52.